Biohaven Ltd (BHVN)

$11.15 +0.34 (3.15%)
Market Cap 1.14B
Revenue (ttm) 0.00
Net Income (ttm) -846.42M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -15.63
Volume 8,260,500
Avg Vol 4,245,276
Day's Range N/A - N/A
Shares Out 105.86M
Stochastic %K 72%
Beta 1.13
Analysts Strong Sell
Price Target $19.80

Company Profile

Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide. The company develops troriluzole, which is in Phase 3 trial for the treatment of neurological and neuropsychiatric illnesses; taldefgrobep alfa, which is in Phase 3 clinical trial for the treatment of spinal muscular atrophy and obesity; BHV-7000, a candidate in Phase 3 clinical trial for the treatment of focal and generalized epilepsy, and major depressive disorder; BHV-2100 tha...

Industry: Biotechnology
Sector: Healthcare
Phone: 203 404 0410
Address:
215 Church Street, New Haven, United States
UgoGreg
UgoGreg Dec. 27 at 12:21 PM
$BHVN https://youtu.be/SWahxjFdqX0
0 · Reply
Joby099
Joby099 Dec. 27 at 6:19 AM
$BHVN
0 · Reply
AmyG28
AmyG28 Dec. 27 at 3:06 AM
$BHVN focus is good.
0 · Reply
FRAGMENTS
FRAGMENTS Dec. 27 at 12:35 AM
$BHVN $PLTR $TSLA $AMZN
0 · Reply
Timefortendies77
Timefortendies77 Dec. 26 at 11:50 PM
$BHVN Seems like institutions bought the shiz out of the DIP right at open.
0 · Reply
Joby099
Joby099 Dec. 26 at 10:48 PM
$BHVN
0 · Reply
RunnerSignals
RunnerSignals Dec. 26 at 9:38 PM
Comeback Kings 👑 $BHVN $GLSI $OMER $HTZ $MVIS They hit the mat counted to nine then stood back up swinging
0 · Reply
BapoRothstein
BapoRothstein Dec. 26 at 8:32 PM
$BHVN Triple daily volume red to green reversal. I’d say the depression data hysterics look straight up retarded at this point.
1 · Reply
Pika_Capital
Pika_Capital Dec. 26 at 8:00 PM
$BHVN out for 35% profit. Redeployed proceeds into $NRIX Bhvn full of sh*t.
1 · Reply
Onyx99
Onyx99 Dec. 26 at 4:56 PM
$BHVN And back to green, well, well.
0 · Reply
Latest News on BHVN
US Stocks Mixed; Biohaven Shares Fall

Dec 26, 2025, 9:45 AM EST - 1 day ago

US Stocks Mixed; Biohaven Shares Fall

Cautiously Bullish After Biohaven's Cash Runway And Dilution Risk Rise

Dec 26, 2025, 9:24 AM EST - 1 day ago

Cautiously Bullish After Biohaven's Cash Runway And Dilution Risk Rise

Biohaven Misses The Mark In Depression Trial, Stock Falls

Dec 26, 2025, 8:20 AM EST - 1 day ago

Biohaven Misses The Mark In Depression Trial, Stock Falls

Stock Market Today: Dow Jones, S&P 500 Futures Slip After Christmas Day—Nvidia, Sobr Safe, Biohaven In Focus

Dec 26, 2025, 5:09 AM EST - 1 day ago

Stock Market Today: Dow Jones, S&P 500 Futures Slip After Christmas Day—Nvidia, Sobr Safe, Biohaven In Focus

IVV SOBR SPXL SPY SSO UPRO VOO

Biohaven's depression drug fails mid-stage trial, shares fall

Dec 24, 2025, 3:24 PM EST - 3 days ago

Biohaven's depression drug fails mid-stage trial, shares fall

Biohaven Provides Update From Phase 2 Proof-of-Concept Study with BHV-7000 in Major Depressive Disorder

Dec 24, 2025, 1:00 PM EST - 3 days ago

Biohaven Provides Update From Phase 2 Proof-of-Concept Study with BHV-7000 in Major Depressive Disorder

Biohaven Presents Clinical Safety and Efficacy Data for BHV-1510, a Next-Generation Trop2 Antibody Drug Conjugate in Combination with Cemiplimab at the 2025 European Society for Medical Oncology (ESMO) Immuno-Oncology Congress

Dec 11, 2025, 7:00 AM EST - 16 days ago

Biohaven Presents Clinical Safety and Efficacy Data for BHV-1510, a Next-Generation Trop2 Antibody Drug Conjugate in Combination with Cemiplimab at the 2025 European Society for Medical Oncology (ESMO) Immuno-Oncology Congress

Biohaven Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $200M

Nov 13, 2025, 4:05 PM EST - 6 weeks ago

Biohaven Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $200M

Biohaven Q3 Earnings: Falling Back To Earth With A Thud

Nov 12, 2025, 3:54 PM EST - 6 weeks ago

Biohaven Q3 Earnings: Falling Back To Earth With A Thud

FLEX LNG, Biohaven And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Nov 12, 2025, 8:10 AM EST - 6 weeks ago

FLEX LNG, Biohaven And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

FLNG

Biohaven Announces Pricing of $175 Million Public Offering of Common Shares

Nov 12, 2025, 7:15 AM EST - 6 weeks ago

Biohaven Announces Pricing of $175 Million Public Offering of Common Shares

Biohaven Announces Proposed Public Offering of Common Shares

Nov 11, 2025, 4:05 PM EST - 6 weeks ago

Biohaven Announces Proposed Public Offering of Common Shares

Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments

Nov 10, 2025, 6:58 AM EST - 6 weeks ago

Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments

Biohaven Stock Hits 52-Week Low, Cuts R&D Spending After FDA Rejection

Nov 5, 2025, 12:53 PM EST - 7 weeks ago

Biohaven Stock Hits 52-Week Low, Cuts R&D Spending After FDA Rejection

Biohaven shares plunge after US FDA declines to approve brain disorder drug

Nov 5, 2025, 10:02 AM EST - 7 weeks ago

Biohaven shares plunge after US FDA declines to approve brain disorder drug

FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia

Nov 4, 2025, 8:06 PM EST - 7 weeks ago

FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. Lawsuit – BHVN

Sep 10, 2025, 3:39 PM EDT - 3 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. Lawsuit – BHVN

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Sep 6, 2025, 10:03 AM EDT - 4 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Aug 28, 2025, 6:55 PM EDT - 4 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Biohaven: Despite Troriluzole Program Delay, FDA Review On Track For Q4 2025

Aug 25, 2025, 8:00 AM EDT - 4 months ago

Biohaven: Despite Troriluzole Program Delay, FDA Review On Track For Q4 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Aug 22, 2025, 10:05 AM EDT - 4 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Biohaven Reports Second Quarter 2025 Financial Results and Recent Business Developments

Aug 11, 2025, 7:00 AM EDT - 4 months ago

Biohaven Reports Second Quarter 2025 Financial Results and Recent Business Developments

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. Lawsuit - BHVN

Aug 4, 2025, 8:45 AM EDT - 5 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. Lawsuit - BHVN

Law Offices of Frank R. Cruz Encourages Biohaven Ltd.

Jul 18, 2025, 12:06 PM EDT - 5 months ago

Law Offices of Frank R. Cruz Encourages Biohaven Ltd.

Law Offices of Howard G. Smith Encourages Biohaven Ltd.

Jul 18, 2025, 12:00 PM EDT - 5 months ago

Law Offices of Howard G. Smith Encourages Biohaven Ltd.

Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Biohaven Ltd. (BHVN)

Jul 15, 2025, 10:46 AM EDT - 5 months ago

Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Biohaven Ltd. (BHVN)

Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development

Jun 10, 2025, 2:00 PM EDT - 7 months ago

Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development

UgoGreg
UgoGreg Dec. 27 at 12:21 PM
$BHVN https://youtu.be/SWahxjFdqX0
0 · Reply
Joby099
Joby099 Dec. 27 at 6:19 AM
$BHVN
0 · Reply
AmyG28
AmyG28 Dec. 27 at 3:06 AM
$BHVN focus is good.
0 · Reply
FRAGMENTS
FRAGMENTS Dec. 27 at 12:35 AM
$BHVN $PLTR $TSLA $AMZN
0 · Reply
Timefortendies77
Timefortendies77 Dec. 26 at 11:50 PM
$BHVN Seems like institutions bought the shiz out of the DIP right at open.
0 · Reply
Joby099
Joby099 Dec. 26 at 10:48 PM
$BHVN
0 · Reply
RunnerSignals
RunnerSignals Dec. 26 at 9:38 PM
Comeback Kings 👑 $BHVN $GLSI $OMER $HTZ $MVIS They hit the mat counted to nine then stood back up swinging
0 · Reply
BapoRothstein
BapoRothstein Dec. 26 at 8:32 PM
$BHVN Triple daily volume red to green reversal. I’d say the depression data hysterics look straight up retarded at this point.
1 · Reply
Pika_Capital
Pika_Capital Dec. 26 at 8:00 PM
$BHVN out for 35% profit. Redeployed proceeds into $NRIX Bhvn full of sh*t.
1 · Reply
Onyx99
Onyx99 Dec. 26 at 4:56 PM
$BHVN And back to green, well, well.
0 · Reply
Few_erish
Few_erish Dec. 26 at 4:32 PM
$BHVN Biotech days like this love traps, pop toward 11 then instant reject is the classic stop run and liquidity grab
1 · Reply
Reneejordan001
Reneejordan001 Dec. 26 at 4:29 PM
$BHVN I must admit, this recovered nicer than I thought
0 · Reply
Ohzipit
Ohzipit Dec. 26 at 4:23 PM
$BHVN RJ remains Strong Buy target $50
0 · Reply
Timefortendies77
Timefortendies77 Dec. 26 at 4:22 PM
$BHVN does 14 feel pretty low if they hit on Epilepsy? Or they are just setting conservative expectations? This could easily be a 20 stock in no time if P2/3 is good.
0 · Reply
Ohzipit
Ohzipit Dec. 26 at 4:20 PM
$BHVN Raymond James update- BHV-7000 Depression Failure Not a Surprise; Keep Your Eye on the Prize
0 · Reply
Timefortendies77
Timefortendies77 Dec. 26 at 4:19 PM
$BHVN I think the bankers jumped in on buying the dip this AM. Risk is off now.
0 · Reply
notreload_ai
notreload_ai Dec. 26 at 4:16 PM
Citi said the result was disappointing, but expectations were "already low." Citi still rates $BHVN a Buy with a $14 target, as investors focus on Phase 3 epilepsy results expected in early 2026.
0 · Reply
Synergiex
Synergiex Dec. 26 at 4:08 PM
$BHVN lol gotta love biotech. what a bipolar stock
0 · Reply
Don_Frye
Don_Frye Dec. 26 at 3:50 PM
$BHVN scratching my head here.. cutting cost ..
0 · Reply
Timefortendies77
Timefortendies77 Dec. 26 at 3:49 PM
$BHVN BS couldn't even get out of options this AM after the drop, so pissed at this low volume and non liquidity on the options front. Shares only in this stock.
0 · Reply
binhtho
binhtho Dec. 26 at 3:49 PM
$BHVN
0 · Reply
www_larval_com
www_larval_com Dec. 26 at 3:47 PM
Dur-dur look @ $BHVN has jumped 3% higher to 0% (~3Mv) moments ago, 01/16 options, follow for more volatility.
0 · Reply